Concepedia

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

Thomas G. Evans, M. Juliana McElrath, David C. Montefiori, Kent J. Weinhold, Mark Wolff, Michael C. Keefer, Esper G. Kallás, Geoffrey J. Gorse, Robert B. Belshe, Barney S. Graham,

Vaccine · 2001 · 138 citations · 39 references

DOI

Concepts

References

39

Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection

Yunzhen Cao, Limo Qin, Linqi Zhang et al. · New England Journal of Medicine · 1995 · 1K citations · Full text

, , +12

Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex

Charlotte R. Kensil, Urmila H. Patel, Michael Lennick et al. · The Journal of Immunology · 1991 · 652 citations · Full text

, , +13

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

John R. Mascola, S W Snyder, O. S. Weislow et al. · The Journal of Infectious Diseases · 1996 · 434 citations

, , +10

Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive Infection

Alice K. Pilgrim, Giuseppe Pantaleo, Oren J. Cohen et al. · The Journal of Infectious Diseases · 1997 · 322 citations · Full text

, , +12

Saponins as vaccine adjuvants.

Kensil Cr · PubMed · 1996 · 296 citations

, , +16